Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Momelotinib Combined With Capecitabine and Oxaliplatin in Adults With Relapsed/Refractory Metastatic Pancreatic Ductal Adenocarcinoma

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT02244489
Recruitment Status : Terminated
First Posted : September 19, 2014
Last Update Posted : February 1, 2019
Sponsor:
Information provided by (Responsible Party):
Sierra Oncology, Inc.

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Terminated
Actual Primary Completion Date : March 8, 2017
Actual Study Completion Date : April 5, 2017